ÂÜÀòÂÒÂ×

Peter Schiemann is the Managing Partner of Widler & Schiemann Ltd., where Peter has been since March 2012. Additionally, Peter serves as the CEO & Chairman of the Board at Ymmunobio since September 2021, and is a Co-Founder & Member of the Board of Directors at iQure Pharma Inc. since January 2019. Peter is also an Associate Partner at LSCP Life Sciences Consulting Partners and has previous experience as the Global Head of Quality Risk Management at Hoffmann-La Roche. Peter holds a PhD in Human Biology and various certificates in marketing strategy, managing the global enterprise, and pharmaceutical medicine.